YD Bio Limited

Healthcare · Biotechnology · Taiwan

Last price 5.94 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 420.74M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

YD Bio Limited, a biopharmaceutical company, focuses on regulated diagnostics, life science clinical services, and healthcare product commercialization in the United States and Taiwan. The company offers eye disease treatment products, 3D LensMate Artificial Tears, a natural tear-mimicking lubricant that moisturizes the eyes and relieves dry eye symptoms; 3D LensMate Eye Drops, an ophthalmic solution to alleviate symptoms of dry eye syndrome, including irritation, foreign body sensation, and eye fatigue; and LSC Eye Drug/Injection, an injectabl...